Analysis of T cell numbers within the tumor showed a significant increase in the number of human CD4+ and a trend towards increased CD8+ T cell numbers in tumors treated with NC410 compared to control (Figure 5C, D). The gene discussed is CD8A; the disease is neoplasm.